热门资讯> 正文

Envoy Medical重新获得纳斯达克合规性

2026-02-24 21:40

Envoy Medical, Inc. Class A(COCH) 0

Envoy Medical (NASDAQ:COCH) announced on Tuesday that Nasdaq notified the company it had regained compliance with Listing Rule 5550(b)(2) under alternatives permitted by Rule 5550(b).
The company said it had received a Nasdaq notice on Feb. 25, 2025, for non-compliance with the minimum $35M market value of listed securities requirement.
The company said it believed it had an achievable plan to maintain compliance.

More on Envoy Medical

Envoy Medical announces pricing of up to $78M public offering
Seeking Alpha’s Quant Rating on Envoy Medical
Financial information for Envoy Medical

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。